References
- Andre T. Studies on the distribution of tritium-labelled dihydrostreptomycin and tetramycin in the bodyl. Acta radiol., Stockh. 1956; 1–89, Suppl. 142
- D'Angelo E. P., Patterson W. C., Morrow R. C. Chloramphenicol. Topical application in the middle ear. Arch. Otolaryng. 1967; 85: 682–684
- Berg K. The toxic effect of streptomycin on the vestibular and cochlear apparatus. An experimental study on cats. Acta oto-laryng., Stockh. 1951; 75, Suppl. 97
- Engström H, Ades H. W., Hawkins J. E., Jr. Cytoarchitecture of the organ of Corti. Acta oto-laryng., Stockh. 1964, Suppl. 188
- Glorig A. The effect of dihydrostreptomycin hydrochloride and sulfate on the auditory mechanism. Ann. Otol. Rhinol. Laryng., St. Louis 1951; 60: 327
- Gulick W. L., Patterson W. C. The effects of chloramphenicol upon the electrical activity of the ear. II. Long-term data. Ann. Otol. Rhinol. Laryng., St. Louis 1964; 73: 204–209
- Hawkins J. E. jr. The ototoxicity of neomycin. Trans. 11th Conf. Tuberc., Veter. Administr., Washington 1952
- Hawkins J. E. jr. The ototoxicity of kanamycin. Ann. Otol. Rhinol. Laryng., St. Louis 1954; 68: 698–715
- Hawkins J. E., Jr., Lurie M. H. The ototoxicity of streptomycin. Ann. Otol. Rhinol. Laryng., St. Louis 1952; 61: 789–806
- Hawkins J. E., Jr., Lurie M. H. The ototoxicity of dihydrostreptomycin and neomycin in the cat. Ann. Otol. Rhinol. Laryng., St. Louis 1953; 62: 1128–1148
- Holtz E., Stange G., Terayama Y. Minderung der Ototoxizität des Streptomycins anhand tierexperimenteller Untersuchungen. IV. Int. Kongr. Infektionskrankheiten 1966
- Koide Y., Hata A., Hando R. Vulnerability of the organ of Corti in poisoning. Acta oto-laryng., Stockh. 1966; 61: 332–344
- Muraveiskaya V. S. Determination of streptomycin, dihydrostreptomycin, colimycin, and monomycin in labyrinth fluid of guinea pigs. Antibiotiki 1965; 10: 245
- Neubert K. Zur morphologischen Erfassung der Ansprechgebiete im Innenohr. Verh. anat. Ges., Jena 1952; 50: 204–209
- Ritter R., Chou J., Ilberg v., Wagner W. H. Eine neue Möglichkeit zur Verhinderung der Ototoxizität des Streptomycins. Arch. klin. exp. Ohr.Nas.-KehlkHeilk. 1971; 199: 573–577
- Rüedi L. Therapeutic and toxic effects of streptomycin in otology. Latyngoscope 1951; 61: 613
- Rüedi L., Graf K., Tschirren B. Vorläufige Mitteilung über die toxische Wirkung von Neomycin auf das Gehörorgan des Meerschweinchens. Schweiz. med. Wschr. 1953; 83: 951–953
- Stupp H., Rauch S., Sous H., Lagler F., Brun J. P. Die Ursache der spezifischen Ototoxizität der basischen Streptomycesantibiotika ein Permeabilitätsproblem. Méd. Hyg. 1965; 23: 988–990
- Vabrec D. P., Cody T., Ulrich J. A. Antibiotic concentration levels in perilymph studies. J. amer. med. Ass. 1965; 193: 29
- Voldrich L. The kinetics of streptomycin, kanamycin, and neomycin in the inner ear. Acta Otolaryng., Stockh. 1965; 60: 243
- Wagner W.-H., Ritter R. Active of passive transport of streptomycin to the perilymph. II. Quantitative analysis of experimental data. Presented 9th Colloquium on Inner Ear Biology. London 1972